C

Cour Pharmaceuticals Development Company, Inc.

45 employees

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Therapeutics

Immune Tolerance

Immunology

Inflammation

Nanomedicine

Nanotechnology

Pharmaceuticals

2015